Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Gains from Investment Securities: 2024

Historic Gains from Investment Securities for Sunshine Biopharma (SBFM) over the last 1 years, with Dec 2024 value amounting to $582,483.

  • Sunshine Biopharma's Gains from Investment Securities was N/A to -$373,529 in Q4 2024 from the same period last year, while for Dec 2024 it was $582,483, marking a year-over-year change of. This contributed to the annual value of $582,483 for FY2024, which is N/A change from last year.
  • Per Sunshine Biopharma's latest filing, its Gains from Investment Securities stood at $582,483 for FY2024.
  • Over the past 5 years, Sunshine Biopharma's Gains from Investment Securities peaked at $582,483 during FY2024, and registered a low of $582,483 during FY2024.
  • In the last 1 years, Sunshine Biopharma's Gains from Investment Securities had a median value of $582,483 in 2024 and averaged $582,483.